The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial,Therapeutic Advances in Medical Oncology

当前位置： X-MOL 学术 › Ther. Adv. Med. Oncol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial
Therapeutic Advances in Medical Oncology ( IF 4.3 ) Pub Date : 2020-02-27 , DOI: 10.1177/1758835919888999
Sara Bravaccini ₁ , Giuseppe Bronte ₁ , Emanuela Scarpi ₂ , Sara Ravaioli ₁ , Roberta Maltoni ₁ , Anita Mangia ₃ , Maria Maddalena Tumedei ₁ , Maurizio Puccetti ₄ , Patrizia Serra ₁ , Lorenzo Gianni ₅ , Laura Amaducci ₆ , Nicoletta Biglia ₇ , Valentina Bounous ₇ , Angelo Virgilio Paradiso ₈ , Rosella Silvestrini ₉ , Dino Amadori ₁ , Andrea Rocca ₁

Affiliation

An estimate of prognosis in patients operated for early breast cancer (BC) is crucial to any decision about optimal systemic adjuvant treatment. Choice should also be guided by the predicted sensitivity to treatments, including endocrine therapy and chemotherapy.

中文翻译：